Lokelma
Lokelma
Too many doctors attempt to manage high blood potassium by reducing their patients’ vital heart medications. AstraZeneca launched a global campaign to urge doctors to rethink this strategy and consider safer options.
Too many doctors attempt to manage high blood potassium by reducing their patients’ vital heart medications. AstraZeneca launched a global campaign to urge doctors to rethink this strategy and consider safer options.